MovDisordV3, Ncbi, Merge, bibRecord, 004254

Effect of neurostimulation on camptocormia in Parkinson's disease depends on symptom duration.

Identifieur interne : 004254 ( Ncbi/Merge ); précédent : 004253; suivant : 004255

Effect of neurostimulation on camptocormia in Parkinson's disease depends on symptom duration.

Auteurs : Walter J. Schulz-Schaeffer [Allemagne] ; Nils G. Margraf ; Sari Munser ; Arne Wrede ; Carsten Buhmann ; Günther Deuschl ; Christian Oehlwein

Source :

Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2015.

RBID : pubmed:25678310

Abstract

Although some reports on neurostimulation are positive, no effective treatment method for camptocormia in Parkinson's disease (PD) is known to date. We aim to identify prognostic factors for a beneficial DBS effect on camptocormia. In an observational cohort study, we investigated 25 idiopathic PD patients, who suffered additionally from camptocormia, and underwent bilateral neurostimulation of the subthalamic nucleus (STN) to improve classical PD symptoms. Using an established questionnaire, we examined deep brain stimulation (DBS) effects on camptocormia in addition to general neurostimulation effects. A beneficial neurostimulation effect on camptocormia was defined as an improvement in the bending angle of a least 50%. In 13 patients, the bending angle of camptocormia improved, in 12 patients it did not. A multifactorial analysis revealed a short duration between onset of camptocormia and start of neurostimulation to be the relevant factor for outcome. All patients with duration of camptocormia up to 1.5 years showed a beneficial effect; patients between 1.5 and ∼3 years showed mixed results, but none with a duration of more than 40 months improved except for 1 patient whose camptocormia was levodopa responsive. The bending angle was not a prognostic factor. Our data indicate that the main prognostic factor for a beneficial DBS effect on camptocormia is its short duration. As an explanation, we suggest that neurostimulation may improve camptocormia only as long as muscle pathology is limited. Our findings may help to elucidate the mode of action of neurostimulation. A prospective study is necessary.

DOI: 10.1002/mds.26081
PubMed: 25678310

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000261
to stream PubMed, to step Curation: 000261
to stream PubMed, to step Checkpoint: 000251

Links to Exploration step

pubmed:25678310

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effect of neurostimulation on camptocormia in Parkinson's disease depends on symptom duration.</title>
<author><name sortKey="Schulz Schaeffer, Walter J" sort="Schulz Schaeffer, Walter J" uniqKey="Schulz Schaeffer W" first="Walter J" last="Schulz-Schaeffer">Walter J. Schulz-Schaeffer</name>
<affiliation wicri:level="3"><nlm:affiliation>Prion and Dementia Research Unit, Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Prion and Dementia Research Unit, Institute of Neuropathology, University Medical Center Göttingen, Göttingen</wicri:regionArea>
<placeName><region type="land" nuts="2">Basse-Saxe</region>
<settlement type="city">Göttingen</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Margraf, Nils G" sort="Margraf, Nils G" uniqKey="Margraf N" first="Nils G" last="Margraf">Nils G. Margraf</name>
</author>
<author><name sortKey="Munser, Sari" sort="Munser, Sari" uniqKey="Munser S" first="Sari" last="Munser">Sari Munser</name>
</author>
<author><name sortKey="Wrede, Arne" sort="Wrede, Arne" uniqKey="Wrede A" first="Arne" last="Wrede">Arne Wrede</name>
</author>
<author><name sortKey="Buhmann, Carsten" sort="Buhmann, Carsten" uniqKey="Buhmann C" first="Carsten" last="Buhmann">Carsten Buhmann</name>
</author>
<author><name sortKey="Deuschl, Gunther" sort="Deuschl, Gunther" uniqKey="Deuschl G" first="Günther" last="Deuschl">Günther Deuschl</name>
</author>
<author><name sortKey="Oehlwein, Christian" sort="Oehlwein, Christian" uniqKey="Oehlwein C" first="Christian" last="Oehlwein">Christian Oehlwein</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25678310</idno>
<idno type="pmid">25678310</idno>
<idno type="doi">10.1002/mds.26081</idno>
<idno type="wicri:Area/PubMed/Corpus">000261</idno>
<idno type="wicri:Area/PubMed/Curation">000261</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000251</idno>
<idno type="wicri:Area/Ncbi/Merge">004254</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Effect of neurostimulation on camptocormia in Parkinson's disease depends on symptom duration.</title>
<author><name sortKey="Schulz Schaeffer, Walter J" sort="Schulz Schaeffer, Walter J" uniqKey="Schulz Schaeffer W" first="Walter J" last="Schulz-Schaeffer">Walter J. Schulz-Schaeffer</name>
<affiliation wicri:level="3"><nlm:affiliation>Prion and Dementia Research Unit, Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Prion and Dementia Research Unit, Institute of Neuropathology, University Medical Center Göttingen, Göttingen</wicri:regionArea>
<placeName><region type="land" nuts="2">Basse-Saxe</region>
<settlement type="city">Göttingen</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Margraf, Nils G" sort="Margraf, Nils G" uniqKey="Margraf N" first="Nils G" last="Margraf">Nils G. Margraf</name>
</author>
<author><name sortKey="Munser, Sari" sort="Munser, Sari" uniqKey="Munser S" first="Sari" last="Munser">Sari Munser</name>
</author>
<author><name sortKey="Wrede, Arne" sort="Wrede, Arne" uniqKey="Wrede A" first="Arne" last="Wrede">Arne Wrede</name>
</author>
<author><name sortKey="Buhmann, Carsten" sort="Buhmann, Carsten" uniqKey="Buhmann C" first="Carsten" last="Buhmann">Carsten Buhmann</name>
</author>
<author><name sortKey="Deuschl, Gunther" sort="Deuschl, Gunther" uniqKey="Deuschl G" first="Günther" last="Deuschl">Günther Deuschl</name>
</author>
<author><name sortKey="Oehlwein, Christian" sort="Oehlwein, Christian" uniqKey="Oehlwein C" first="Christian" last="Oehlwein">Christian Oehlwein</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Although some reports on neurostimulation are positive, no effective treatment method for camptocormia in Parkinson's disease (PD) is known to date. We aim to identify prognostic factors for a beneficial DBS effect on camptocormia. In an observational cohort study, we investigated 25 idiopathic PD patients, who suffered additionally from camptocormia, and underwent bilateral neurostimulation of the subthalamic nucleus (STN) to improve classical PD symptoms. Using an established questionnaire, we examined deep brain stimulation (DBS) effects on camptocormia in addition to general neurostimulation effects. A beneficial neurostimulation effect on camptocormia was defined as an improvement in the bending angle of a least 50%. In 13 patients, the bending angle of camptocormia improved, in 12 patients it did not. A multifactorial analysis revealed a short duration between onset of camptocormia and start of neurostimulation to be the relevant factor for outcome. All patients with duration of camptocormia up to 1.5 years showed a beneficial effect; patients between 1.5 and ∼3 years showed mixed results, but none with a duration of more than 40 months improved except for 1 patient whose camptocormia was levodopa responsive. The bending angle was not a prognostic factor. Our data indicate that the main prognostic factor for a beneficial DBS effect on camptocormia is its short duration. As an explanation, we suggest that neurostimulation may improve camptocormia only as long as muscle pathology is limited. Our findings may help to elucidate the mode of action of neurostimulation. A prospective study is necessary.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="In-Process"><PMID Version="1">25678310</PMID>
<DateCreated><Year>2015</Year>
<Month>03</Month>
<Day>11</Day>
</DateCreated>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>30</Volume>
<Issue>3</Issue>
<PubDate><Year>2015</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of neurostimulation on camptocormia in Parkinson's disease depends on symptom duration.</ArticleTitle>
<Pagination><MedlinePgn>368-72</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.26081</ELocationID>
<Abstract><AbstractText>Although some reports on neurostimulation are positive, no effective treatment method for camptocormia in Parkinson's disease (PD) is known to date. We aim to identify prognostic factors for a beneficial DBS effect on camptocormia. In an observational cohort study, we investigated 25 idiopathic PD patients, who suffered additionally from camptocormia, and underwent bilateral neurostimulation of the subthalamic nucleus (STN) to improve classical PD symptoms. Using an established questionnaire, we examined deep brain stimulation (DBS) effects on camptocormia in addition to general neurostimulation effects. A beneficial neurostimulation effect on camptocormia was defined as an improvement in the bending angle of a least 50%. In 13 patients, the bending angle of camptocormia improved, in 12 patients it did not. A multifactorial analysis revealed a short duration between onset of camptocormia and start of neurostimulation to be the relevant factor for outcome. All patients with duration of camptocormia up to 1.5 years showed a beneficial effect; patients between 1.5 and ∼3 years showed mixed results, but none with a duration of more than 40 months improved except for 1 patient whose camptocormia was levodopa responsive. The bending angle was not a prognostic factor. Our data indicate that the main prognostic factor for a beneficial DBS effect on camptocormia is its short duration. As an explanation, we suggest that neurostimulation may improve camptocormia only as long as muscle pathology is limited. Our findings may help to elucidate the mode of action of neurostimulation. A prospective study is necessary.</AbstractText>
<CopyrightInformation>© 2015 International Parkinson and Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schulz-Schaeffer</LastName>
<ForeName>Walter J</ForeName>
<Initials>WJ</Initials>
<AffiliationInfo><Affiliation>Prion and Dementia Research Unit, Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Margraf</LastName>
<ForeName>Nils G</ForeName>
<Initials>NG</Initials>
</Author>
<Author ValidYN="Y"><LastName>Munser</LastName>
<ForeName>Sari</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Wrede</LastName>
<ForeName>Arne</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Buhmann</LastName>
<ForeName>Carsten</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Deuschl</LastName>
<ForeName>Günther</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Oehlwein</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>02</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Parkinson's disease</Keyword>
<Keyword MajorTopicYN="N">camptocormia</Keyword>
<Keyword MajorTopicYN="N">deep brain stimulation</Keyword>
<Keyword MajorTopicYN="N">nucleus subthalamicus</Keyword>
<Keyword MajorTopicYN="N">proprioception</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>3</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2014</Year>
<Month>10</Month>
<Day>6</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>10</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint"><Year>2015</Year>
<Month>2</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>2</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>2</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>2</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25678310</ArticleId>
<ArticleId IdType="doi">10.1002/mds.26081</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Allemagne</li>
</country>
<region><li>Basse-Saxe</li>
</region>
<settlement><li>Göttingen</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Buhmann, Carsten" sort="Buhmann, Carsten" uniqKey="Buhmann C" first="Carsten" last="Buhmann">Carsten Buhmann</name>
<name sortKey="Deuschl, Gunther" sort="Deuschl, Gunther" uniqKey="Deuschl G" first="Günther" last="Deuschl">Günther Deuschl</name>
<name sortKey="Margraf, Nils G" sort="Margraf, Nils G" uniqKey="Margraf N" first="Nils G" last="Margraf">Nils G. Margraf</name>
<name sortKey="Munser, Sari" sort="Munser, Sari" uniqKey="Munser S" first="Sari" last="Munser">Sari Munser</name>
<name sortKey="Oehlwein, Christian" sort="Oehlwein, Christian" uniqKey="Oehlwein C" first="Christian" last="Oehlwein">Christian Oehlwein</name>
<name sortKey="Wrede, Arne" sort="Wrede, Arne" uniqKey="Wrede A" first="Arne" last="Wrede">Arne Wrede</name>
</noCountry>
<country name="Allemagne"><region name="Basse-Saxe"><name sortKey="Schulz Schaeffer, Walter J" sort="Schulz Schaeffer, Walter J" uniqKey="Schulz Schaeffer W" first="Walter J" last="Schulz-Schaeffer">Walter J. Schulz-Schaeffer</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004254 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 004254 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:25678310
   |texte=   Effect of neurostimulation on camptocormia in Parkinson's disease depends on symptom duration.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:25678310" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Effect of neurostimulation on camptocormia in Parkinson's disease depends on symptom duration.

Effect of neurostimulation on camptocormia in Parkinson's disease depends on symptom duration.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki